Review: could Remicade cause Anaphylactic Shock?


Anaphylactic shock is found among people who take Remicade, especially for people who are female, 10-19 old , have been taking the drug for < 1 month, also take medication Methotrexate, and have Crohn's disease . We study 97,680 people who have side effects while taking Remicade from FDA and social media. Among them, 835 have Anaphylactic shock. Find out below who they are, when they have Anaphylactic shock and more.

You are not alone

Join a support group for people who take Remicade and have Anaphylactic shock >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Remicade has active ingredients of infliximab. It is often used in rheumatoid arthritis. (latest outcomes from Remicade 97,983 users)

Anaphylactic Shock

Anaphylactic shock (severe and rapid and sometimes fatal hypersensitivity reaction to a substance) has been reported by people with breathing difficulty, hypotension, rashes, itching, diarrhea (latest reports from 32,528 Anaphylactic shock patients).

On Aug, 26, 2016

97,680 people reported to have side effects when taking Remicade.
Among them, 835 people (0.85%) have Anaphylactic Shock

Number of reports submitted per year:

Could Remicade cause Anaphylactic shock?

Time on Remicade when people have Anaphylactic Shock *:

  • < 1 month: 57.67 %
  • 1 - 6 months: 17.99 %
  • 6 - 12 months: 7.41 %
  • 1 - 2 years: 8.99 %
  • 2 - 5 years: 5.29 %
  • 5 - 10 years: 2.12 %
  • 10+ years: 0.53 %

Gender of people who have Anaphylactic Shock when taking Remicade *:

  • female: 66.71 %
  • male: 33.29 %

Age of people who have Anaphylactic Shock when taking Remicade *:

  • 0-1: 0.15 %
  • 2-9: 6.17 %
  • 10-19: 25.15 %
  • 20-29: 13.55 %
  • 30-39: 15.96 %
  • 40-49: 11.6 %
  • 50-59: 13.7 %
  • 60+: 13.7 %

Top conditions involved for these people *:

  • Crohn's Disease (298 people)
  • Rheumatoid Arthritis (132 people)
  • Colitis Ulcerative (56 people)
  • Psoriatic Arthropathy (32 people)
  • Psoriasis (32 people)

Top co-used drugs for these people *:

  • Methotrexate (130 people)
  • Prednisone (67 people)
  • Prednisolone (52 people)
  • Folic Acid (50 people)
  • Pentasa (49 people)

* Approximation only. Some reports may have incomplete information.

** Reports from social media are used.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you have Anaphylactic shock when taking Remicade?

Browse all side effects of Remicade

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Anaphylactic shock

Anaphylactic shock

Could your condition cause Anaphylactic shock

Anaphylactic shock

Can you answer these questions?

More questions for: Remicade, Anaphylactic shock

You may be interested in these reviews

More reviews for: Remicade, Anaphylactic shock

NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.